Tag: Relenza

According to the Centers for Disease Control and Prevention (CDC), four FDA-approved antiviral drugs are recommended for treating the flu, including the commonly prescribed Tamiflu. However, in situations of shortages, allergies, or other medical contraindications, patients and healthcare providers may seek to understand what's the closest thing to Tamiflu and what options are available.

First approved for public use in 1999, zanamivir (Relenza) was the first commercially available neuraminidase inhibitor specifically designed for the treatment and prevention of influenza. This antiviral medication targets a specific enzyme on the surface of the influenza virus to stop its spread. Understanding what is the mechanism of action of zanamivir relenza reveals how this targeted therapy provides a powerful defense against influenza A and B.